Inside Precision Medicine June 30, 2025
Researchers have developed a new method to 3D print functional human islets that can sustain strong insulin responses for up to three weeks. Using a novel bioink derived from human pancreatic tissue could unlock an innovative, minimally invasive approach to islet transplantation that potentially overcomes some of the major challenges facing the development of cell therapies for type I diabetes.
“This is one of the first studies to use real human islets instead of animal cells in bioprinting, and the results are incredibly promising. It means we’re getting closer to creating an off-the-shelf treatment for diabetes that could one day eliminate the need for insulin injections,” said Quentin Perrier, PhD, researcher at the Wake Forest University School of Medicine,...
Today's Sponsors
Today's Sponsor